Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Demeter

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Pathology Oncology Research : POR|May 3, 2014
Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learntEszter Sári, Zsolt György Nagy, Kornélia Baghy, et al.
Magyar Onkologia|March 9, 2017
[Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia]Júlia Gaál-Weisinger, Orsolya Mucsi, Gábor Körösmezey, et al.
Orvosi Hetilap|August 9, 2021
Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019Júlia Weisinger, Ilona Tárkányi, Eid Hanna, et al.
Immunobiology|October 25, 2016
Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathiesPéter Farkas, Dorottya Csuka, Bálint Mikes, et al.
Hamostaseologie|July 12, 2018
MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the DisorderCarlo Zaninetti, Daniela De Rocco, Tania Giangregorio, et al.
European Journal of Haematology|May 19, 2023
A potentially new thromboembolic event scoring system in polycythaemia vera patients: An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia registerEva Karadi, Peter Dombi, Viktoria Gyorine Korom, et al.
Orvosi Hetilap|September 5, 2021
Long-time progression-free survival in relapsed, refractory multiple myeloma with the oral ixazomib-lenalidomide-dexamethasone regimeApor Hardi, Gergely Varga, Zsolt Nagy, et al.
Orvosi Hetilap|August 15, 2021
Management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopeniaÁgnes Fehér, Ildikó Istenes, Júlia Weisinger, et al.
Orvosi Hetilap|February 8, 2017
[TP53 mutation analysis in chronic lymphocytic leukaemia]Viktória Fésüs, Dóra Marosvári, Béla Kajtár, et al.
Pathology|August 1, 2021
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclaxAmbrus Gángó, Richárd Kiss, Péter Farkas, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Pathology Oncology Research : POR|May 3, 2014
Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learntEszter Sári, Zsolt György Nagy, Kornélia Baghy, et al.
Magyar Onkologia|March 9, 2017
[Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia]Júlia Gaál-Weisinger, Orsolya Mucsi, Gábor Körösmezey, et al.
Orvosi Hetilap|August 9, 2021
Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019Júlia Weisinger, Ilona Tárkányi, Eid Hanna, et al.
Immunobiology|October 25, 2016
Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathiesPéter Farkas, Dorottya Csuka, Bálint Mikes, et al.
Hamostaseologie|July 12, 2018
MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the DisorderCarlo Zaninetti, Daniela De Rocco, Tania Giangregorio, et al.
European Journal of Haematology|May 19, 2023
A potentially new thromboembolic event scoring system in polycythaemia vera patients: An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia registerEva Karadi, Peter Dombi, Viktoria Gyorine Korom, et al.
Orvosi Hetilap|September 5, 2021
Long-time progression-free survival in relapsed, refractory multiple myeloma with the oral ixazomib-lenalidomide-dexamethasone regimeApor Hardi, Gergely Varga, Zsolt Nagy, et al.
Orvosi Hetilap|August 15, 2021
Management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopeniaÁgnes Fehér, Ildikó Istenes, Júlia Weisinger, et al.
Orvosi Hetilap|February 8, 2017
[TP53 mutation analysis in chronic lymphocytic leukaemia]Viktória Fésüs, Dóra Marosvári, Béla Kajtár, et al.
Pathology|August 1, 2021
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclaxAmbrus Gángó, Richárd Kiss, Péter Farkas, et al.
Pageof 9